Related Experiment Video
Updated: Aug 16, 2025
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
3.9K
LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS
Summary
Nd:YAG laser vitreolysis offers subjective improvement for symptomatic vitreous floaters. This safe procedure showed no significant complications, though objective success measurement remains a challenge.
Area of Science:
- Ophthalmology
- Medical Laser Applications
Background:
- Symptomatic vitreous floaters significantly impact patient quality of life.
- Nd:YAG laser vitreolysis is a minimally invasive option for treating vitreous opacities.
Purpose of the Study:
- To evaluate the effectiveness and safety of Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) laser vitreolysis for symptomatic vitreous floaters.
Main Methods:
- A single-center study included 84 patients (89 eyes) treated with Nd:YAG laser vitreolysis.
- Pre- and post-treatment assessments included visual acuity, intraocular pressure, fundus photography, OCT, and subjective floater impact questionnaires.
- Follow-up ranged from 1 to 2 months post-treatment.
Main Results:
- 42% of patients reported subjective improvement, with 9% experiencing complete success and 33% significant success.
- No statistically significant changes in intraocular pressure or best-corrected visual acuity were observed.
- The procedure was safe, with no reported complications such as elevated intraocular pressure, cataract formation, or retinal issues.
Conclusions:
- Nd:YAG laser vitreolysis provides subjective relief from vitreous floater symptoms.
- The study highlights the need for objective measures to assess treatment efficacy.
- Laser vitreolysis appears more effective for solitary vitreous opacities compared to diffuse ones.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
518
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
518
01:28Angle Closure Glaucoma: Treatment
609
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
609
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
22
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
22
01:25Glaucoma: Overview
677
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
677